Cancer News and Research

Latest Cancer News and Research

Genotoxic bacteria in the digestive tract

Escherichia coli is a commensal bacterium, which lives peacefully in our digestive tract. However, certain strains are pathogenic and are frequently incriminated in a broad spectrum of infections, affecting both farmed animals and humans (diarrhoea, urinary tract infections, food poisoning, septicaemia, neonatal meningitis, etc.).

16 Aug 2006

When a patient is diagnosed with prostate cancer, what determines whether he will receive early androgen ablation?

While the benefits of androgen ablation therapy have been well documented in patients with locally advanced and metastatic prostate cancer, there is a paucity of evidence its role in patients with low-grade, low-stage disease.

16 Aug 2006

Trying to improve on the activity of Interferon-Alpha in metastatic renal cell carcinoma

Interferon-alpha (IFN) has been a mainstay in the systemic treatment of metastatic renal cell carcinoma (RCC) for decades, with response rates ranging from 3-15%.

16 Aug 2006

Findings shed new light on BRCA1 and BRCA2 breast-cancer gene mutations in older and African-American women

Clearest picture yet of the prevalence and predictors of mutations in the breast-cancer susceptibility genes BRCA1 and BRCA2 among women in the general population.

15 Aug 2006

Watch and wait the best option for low-risk prostate cancer

According to the American Cancer Society, 234,000 men will be diagnosed with prostate cancer this year, and 27,350 will die from it, but researchers say that as many as half of men diagnosed with low-risk prostate cancer undergo surgery or radiation therapy unnecessarily.

15 Aug 2006

Cancer patient receives first proton therapy treatment

A Cocoa Beach man with prostate cancer has become the first patient to undergo treatment at the new University of Florida Proton Therapy Institute, the first time the most advanced form of radiation therapy available has been offered in the Southeast.

15 Aug 2006

The role of transurethral resection of the prostate and biopsy of the peripheral zone after pepeated negative biopsies in the diagnosis of prostate cancer examined

Persistent suspicion of prostate cancer despite repeated negative prostate biopsies is a common problem in urologic practice.

15 Aug 2006

Major new research grant to develop new technology for delivering cell-by-cell medical treatments

Scientists from the Universities of Dundee and St Andrews have won a major new research grant to develop a completely new technology for delivering cell-by-cell medical treatments.

15 Aug 2006

Drug trial fiasco induced immune system overload in patients

The doctors who treated six British men in a trial of a drug in March which went horribly wrong, say they believe the men suffered an immune system overreaction known as a cytokine storm.

15 Aug 2006

Breast cancer 'wonder drug' Herceptin carries a risk for heart problems

According to the latest research breast cancer wonder drug Herceptin puts some women at risk of heart problems.

15 Aug 2006

Cancer stem cells spur glioma angiogenesis, could hold key to brain tumor therapy

Stem cell-like glioma cancer cells that share many characteristics with normal stem cells propel the lethal growth of brain cancers by promoting tumor blood vessel formation, and may hold the key to treating these deadly cancers.

15 Aug 2006

New findings support Rapamycin's role as cancer treatment

Scientists have long known that the blood vessels of tumors differ markedly from normal blood vessels.

14 Aug 2006

Ancient blue war paint from plant rich in cancer fighting compound

Glucobrassicin, a compound in plants which is known to be an anti-cancer agent has been discovered in a plant that gave ancient Britons and Celts their blue war paint.

14 Aug 2006

Gene test for cancers could mean more effective, tailored-made treatment

Scientists in the United States have developed a test which is able to predict which lung cancer tumours are most likely to recur.

14 Aug 2006

New novel protein-genome interaction mapping technology

Fred Hutchinson Cancer Research Center, The Netherlands Cancer Institute (NKI) and Cancer Research Technology Limited (CRT) today have released details of the development and commercialisation of a powerful protein-genome interaction mapping technology termed 'DamID.'

14 Aug 2006